Author Index

Search or browse for an author across our entire electronic archive

Search results for: Y
Results 81 - 90 of 434 shown below

  • Yamato, I

    I Yamato, M Sho, T Nomi, T Akahori, K Shimada, K Hotta, H Kanehiro, N Konishi, H Yagita and Y Nakajima

    Clinical importance of B7-H3 expression in human pancreatic cancer

    advance online publication, 2009-10-20 00:00:00.000;

    doi:10.1038/sj.bjc.6605375

  • Yamatoji, M

    K Saito, K Uzawa, A Kasamatsu, K Shinozuka, K Sakuma, M Yamatoji, M Shiiba, Y Shino, H Shirasawa and H Tanzawa

    Oncolytic activity of Sindbis virus in human oral squamous carcinoma cells

    advance online publication, 2009-07-28 00:00:00.000;

    doi:10.1038/sj.bjc.6605209

  • Yamauchi, J

    L Ding, M Sunamura, T Kodama, J Yamauchi, D G Duda, H Shimamura, K Shibuya, K Takeda and S Matsuno

    In vivo evaluation of the early events associated with liver metastasis of circulating cancer cells

    doi:10.1054/bjoc.2001.1911

  • Yamaue, H

    Y Shono, H Tanimura, M Iwahashi, T Tsunoda, M Tani, H Tanaka, K Matsuda and H Yamaue

    Specific T-cell immunity against Ki-ras peptides in patients with pancreatic and colorectal cancers

    doi:10.1038/sj.bjc.6600697

  • H Tanaka, T Tsunoda, I Nukaya, A Sette, K Matsuda, Y Umano, H Yamaue, K Takesako and H Tanimura

    Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2 / neu: possible immunotherapy for colorectal carcinomas

    doi:10.1054/bjoc.2000.1547

  • Y Umano, T Tsunoda, H Tanaka, K Matsuda, H Yamaue and H Tanimura

    Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53

    doi:10.1054/bjoc.2000.1715

  • Yamaura, A

    Y Iwadate, S Fujimoto, H Namba and A Yamaura

    Promising survival for patients with glioblastoma multiforme treated with individualised chemotherapy based on in vitro drug sensitivity testing

    doi:10.1038/sj.bjc.6601376

  • Yamaura, T

    Y Doki, K Murakami, T Yamaura, S Sugiyama, T Misaki and I Saiki

    Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice

    doi:10.1038/sj.bjc.6690178

  • Yamawaki, S

    M Kaya, T Wada, S Kawaguchi, S Nagoya, T Yamashita, Y Abe, H Hiraga, K Isu, M Shindoh, F Higashino, F Okada, M Tada, S Yamawaki and S Ishii

    Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma

    doi:10.1038/sj.bjc.6600201

  • M Kobayakawa, S Yamawaki, K Hamazaki, T Akechi, M Inagaki and Y Uchitomi

    Levels of omega-3 fatty acid in serum phospholipids and depression in patients with lung cancer

    advance online publication, 2005-11-22 00:00:00.000;

    doi:10.1038/sj.bjc.6602877

  • Yamazaki, H

    T Tokunaga, M Nakamura, Y Oshika, Y Abe, Y Ozeki, Y Fukushima, H Hatanaka, S Sadahiro, H Kijima, T Tsuchida, H Yamazaki, N Tamaoki and Y Ueyama

    Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer

    doi:10.1038/sj.bjc.6690056

  • T Tokunaga, T Tsuchida, H Kijima, K Okamoto, Y Oshika, N Sawa, Y Ohnishi, H Yamazaki, S Miura, Y Ueyama and M Nakamura

    Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line

    doi:10.1054/bjoc.2000.1363

  • Yamazaki, K

    H Dosaka-Akita, I Kinoshita, K Yamazaki, H Izumi, T Itoh, H Katoh, M Nishimura, K Matsuo, Y Yamada and K Kohno

    N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers

    doi:10.1038/sj.bjc.6600536

  • T Sasaki, K Yamazaki, T Yamori and T Endo

    Inhibition of proliferation and induction of differentiation of glioma cells with Datura stramonium agglutinin

    doi:10.1038/sj.bjc.6600550

  • H Asahina, K Yamazaki, I Kinoshita, N Sukoh, M Harada, H Yokouchi, T Ishida, S Ogura, T Kojima, Y Okamoto, Y Fujita, H Dosaka–akita, H Isobe and M Nishimura

    A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations

    doi:10.1038/sj.bjc.6603393

  • H Asahina, K Yamazaki and I Kinoshita

    Reply: Appropriate prospective trials are warranted to determine differences between exon 19 deletions and L858R EGFR mutations in non-small cell lung cancer

    advance online publication, 2007-01-09 00:00:00.000;

    doi:10.1038/sj.bjc.6603565

  • Y Tajima, K Yamazaki, R Makino, N Nishino, Y Masuda, S Aoki, M Kato, K Morohara and M Kusano

    Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach

    advance online publication, 2007-01-30 00:00:00.000;

    doi:10.1038/sj.bjc.6603583

  • Y Shimizu, I Kinoshita, J Kikuchi, K Yamazaki, M Nishimura, M J Birrer and H Dosaka-Akita

    Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant

    advance online publication, 2008-02-19 00:00:00.000;

    doi:10.1038/sj.bjc.6604267

  • Y Park, K Okamura, S Mitsuyama, T Saito, J Koh, S Kyono, K Higaki, M Ogita, T Asaga, H Inaji, H Komichi, N Kohno, K Yamazaki, F Tanaka, T Ito, H Nishikawa, A Osaki, H Koyama and T Suzuki

    Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study

    advance online publication, 2009-07-28 00:00:00.000;

    doi:10.1038/sj.bjc.6605218

  • Y Park, K Okamura, S Mitsuyama, T Saito, J Koh, S Kyono, K Higaki, M Ogita, T Asaga, H Inaji, H Komichi, N Kohno, K Yamazaki, F Tanaka, T Ito, H Nishikawa, A Osaki, H Koyama and T Suzuki

    Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in postoperative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study

    doi:10.1038/sj.bjc.6605295

  • Yamazaki, M

    T Kanai, M Watanabe, A Hayashi, A Nakazawa, T Yajima, A Okazawa, M Yamazaki, H Ishii and T Hibi

    Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion

    doi:10.1054/bjoc.2000.1113